系统性红斑狼疮风险概率指数在未分化结缔组织病队列中的表现
本研究在422例未分化结缔组织病(UCTD)患者中应用系统性红斑狼疮风险概率指数(SLERPI),39例(9.2%)SLERPI评分>7被诊断为系统性红斑狼疮(SLE)。年轻年龄及颧部皮疹、黏膜溃疡、脱发、ANA阳性、低C3和C4、蛋白尿>500 mg/24 h、血小板减少或自身免疫性溶血性贫血者更易满足SLERPI的SLE标准。作者认为该指数可能有助于在具有CTD表现但未满足明确分类标准的患者中早期识别SLE。
要点
- 422例UCTD患者中39例(9.2%)SLERPI评分>7被诊断为SLE。
- SLERPI中位(四分位距)评分为4.25(2.5)分。
- 年轻年龄及颧部皮疹、黏膜溃疡、脱发、ANA阳性、低C3和C4、蛋白尿>500 mg/24 h、血小板减少或自身免疫性溶血性贫血与满足SLERPI的SLE标准相关。
核心结论
- SLERPI使本UCTD队列中相当比例的患者被识别为SLE。
- 作者认为这一新的概率指数可能有助于在具有CTD表现但未满足任何明确分类标准的患者中早期识别SLE。
研究设计与样本
- 研究在符合UCTD分类标准且不满足包括SLE在内的其他明确CTD分类标准的患者队列中应用SLERPI。
- SLERPI评分>7的患者被「诊断」为SLE,并将诊断为SLE与未诊断为SLE的患者在疾病特征和指数参数方面进行比较。
- 共纳入422例UCTD患者。
主要发现
- SLERPI中位(四分位距)为4.25(2.5)分。
- 39例(9.2%)患者SLERPI评分>7并被诊断为SLE。
- 年轻年龄(P = 0.026)及颧部皮疹(P < 0.0001)、黏膜溃疡(P < 0.0001)、脱发(P < 0.0001)、ANA阳性(P < 0.0001)、低C3和C4(P = 0.002)、蛋白尿>500 mg/24 h(P = 0.001)、血小板减少(P = 0.009)或自身免疫性溶血性贫血(P < 0.0001)的患者更可能满足SLERPI的SLE标准。
关键数值与推荐
- SLERPI评分>7被用于「诊断」SLE。
- 本队列SLERPI中位(四分位距)为4.25(2.5)分。
- 39例(9.2%)患者SLERPI评分>7。
临床怎么用
- 作者认为SLERPI可能有助于在具有CTD表现但未满足任何明确分类标准的患者中早期识别SLE。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We sought to evaluate the performance of the SLE Risk Probability Index (SLERPI) for identification of SLE in a large cohort of patients with UCTD. METHODS: The SLERPI was applied in a cohort of patients who met classification criteria for UCTD and did not fulfil any classification criteria for other defined CTD including SLE. Patients with a SLERPI score of >7 were 'diagnosed' as SLE. Patients diagnosed with SLE and those not were compared in terms of disease characteristics and index parameters. RESULTS: A total of 422 patients with UCTD were included in the study. Median (interquartile range) SLERPI was 4.25 (2.5) points, while 39 (9.2%) patients had a SLERPI score >7 and were diagnosed as SLE. Patients with younger age (P = 0.026) and presence of malar rash (P < 0.0001), mucosal ulcer (P < 0.0001), alopecia (P < 0.0001), ANA positivity (P < 0.0001), low C3 and C4 (P = 0.002), proteinuria >500 mg/24 h (P = 0.001), thrombocytopenia (P = 0.009) or autoimmune haemolytic anaemia (P < 0.0001) were more likely to fulfil criteria for SLE by the SLERPI. CONCLUSION: SLERPI enabled a significant proportion of patients to be identified as SLE in our UCTD cohort. This new probability index may be useful for early identification of SLE among patients with signs of CTD without fulfilling any definite criteria set.
引用
- Erden A, Apaydın H, Fanouriakis A, et al. Performance of the systemic lupus erythematosus risk probability index in a cohort of undifferentiated connective tissue disease. Rheumatology (Oxford). 2022. PMID: 35015853. doi:10.1093/rheumatology/keac005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。